Sponsor Pipeline

Rise Therapeutics LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
3
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1
6
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06398418 R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune… Solid Tumor, Adult Recruiting
NCT05666960 R-3750 in Patients With Mild to Moderate Ulcerative Colitis Ulcerative Colitis Chronic Mild Recruiting
NCT05961592 R-2487 in Patients With Rheumatoid Arthritis Arthritis, Rheumatoid Recruiting
NCT06297213 R-2487 in Patients With Sjogren's Syndrome (SS) Sjogren's Syndrome Not Yet Recruiting
NCT07076290 A Repeat Ascending Dosing Study of the Safety and Clinical Activity of R-3750 in Patients… COPD (Chronic Obstructive Pulmonary Disease) Not Yet Recruiting
NCT07646028 R-3750 in Patients With Late-Stage Acute Respiratory Distress Syndrome (ARDS) Acute Respiratory Distress Syndrome Not Yet Recruiting
Disease Areas
Get alerts when Rise Therapeutics LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free